TITLE

Use of Prostaglandin E2 for Therapeutic Abortion

AUTHOR(S)
Karim, S. M. M.; Filshie, G. M.
PUB. DATE
July 1970
SOURCE
British Medical Journal;7/25/1970, Vol. 3 Issue 5716, p198
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
64321608

 

Related Articles

  • Prostaglandins in human reproduction. Embrey, M.P. // British Medical Journal (Clinical Research Edition);12/12/1981, Vol. 283 Issue 6306, p1563 

    Focuses on the role of prostaglandins in human reproduction. Control of parturition; Factors affecting the therapeutic use of prostaglandins in labor and abortion; Inhibition of corpus luteum.

  • Single Extra-amniotic Injection of Prostaglandin E(sub2) in Viscous Gel to Induce Mid-trimester Abortion. Mackenzie, I.Z.; Hillier, Keith; Embrey, M.P. // British Medical Journal;2/1/1975, Vol. 1 Issue 5952, p240 

    Examines the clinical usefulness of prostaglandins for the induction of mid-trimester abortion in Great Britain. Side effects of prostaglandins; Directions for prostaglandin administration; Efficacy of prostaglandins.

  • Misoprostol--Is More Research Needed? Moore, Mary Lou // Journal of Perinatal Education;2002, Vol. 11 Issue 3, p43 

    Discusses the uses of synthetic prostaglandin E1 misoprostol for obstetrics in the U.S. Administration of the prostaglandin for induction of first and second trimester abortion and the control postpartum hemorrhage; Advantages and disadvantages of the uses; Stand of the Food and Drug...

  • Abortifacient (Major drug group).  // Royal Society of Medicine: Medicines;2002, p27 

    This article presents information on abortifacients, in which drugs are used to induce abortion or miscarriage as a medical alternative to surgical termination. A number of types of drug have been used to procure therapeutic abortion, but commonly the progestogen hormone antagonist drug is used...

  • Misoprostol - A Wonder Drug. Shaheen; Sharma, R. // Bangladesh Journal of Medical Science;Oct2011, Vol. 10 Issue 4, p221 

    Misoprostol is a synthetic analogue of natural prostaglandin E1. It has a very convenient and flexible drug dosing, can be administered orally, sublingually, buccally, rectally and by vaginal route. Misoprostol is useful for elective early medical abortion, cervical ripening in surgical abortion...

  • Rupture of the cervix in a sulprostone induced abortion in the second trimester. Corrado, F.; D'Anna, R.; Cannata, M. L. // Archives of Gynecology & Obstetrics;Nov2000, Vol. 264 Issue 3, p162 

    The authors report one case of cervical rupture in a normal uterus of a 43 years old second gravida, during an abortion at 16 weeks induced by sulprostone, a prostaglandin analogue. Case history and analysis of permittent condictions are listed. They conclude that uterus rupture remains an...

  • Further Tests of Medical Abortion. Klitsch, Michael // Family Planning Perspectives;Jan/Feb95, Vol. 27 Issue 1, p3 

    The article presents update on tests of medical abortion. It reports on the effectivity of oral prostaglandin misoprostol in inducing early first-trimester abortion used with the antiprogestin mifepristone (RU 486). Mifepristone is used as the injectable or suppository prostaglandins. The...

  • Prostaglandins in gel for mid-trimester abortion: a method to minimise nursing involvement.  // British Medical Journal (Clinical Research Edition);6/20/1981, Vol. 282 Issue 6281, p2012 

    Examines the use of prostaglandins in gel for mid-trimester abortion. Minimization of nursing involvement; Complications in the termination of pregnancy in the midtrimester; Need for more surgical expertise.

  • abortifacient. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p8 

    A definition of the term "abortifacient" is presented. It refers to an agent which leads to abortion. Abortion, in medical practice, is induced using prostaglandin drugs. These drugs cause the widening and softening of the neck of the uterus and muscular contractions of the uterus.

  • Prostanoids as anti-inflammatory therapy: separating the good from the bad. Knox, Alan J. // Thorax;Aug2015, Vol. 70 Issue 8, p711 

    The author discusses research "Anti-inflammatory effects of PGE2 in the lung: Role of the EP4 receptor subtype" by M.A. Birrell and others, published in the issue, which identifies prostaglandin E (EP) receptor mediating anti-inflammatory actions of prostaglandin E2 in the lung. It discusses...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics